Safety and technique of ferumoxytol administration for MRI. Issue 5 (18th February 2016)

• Record Type: Journal Article
• Authors: Vasanawala, Shreyas S.; Nguyen, Kim‐Lien; Hope, Michael D.; Bridges, Mellena D.; Hope, Thomas A.; Reeder, Scott B.; Bashir, Mustafa R.
• Is Part Of: Magnetic resonance in medicine. Volume 75:Issue 5(2016)
• Page Start: 2107
• Page End: 2111
• Publication Date: 2016-02-18
• Subjects: ferumoxytol -- iron oxide -- safety -- contrast agent; Nuclear magnetic resonance -- Periodicals; Electron paramagnetic resonance -- Periodicals; 616.07548
• DOI: 10.1002/mrm.26151
• Languages: English
• ISSNs: 0740-3194

Abstract

Abstract : Ferumoxytol is an ultrasmall superparamagnetic iron oxide agent marketed for the treatment of anemia. There has been increasing interest in its properties as an MRI contrast agent as well as greater awareness of its adverse event profile. This mini‐review summarizes the current state of knowledge of the risks of ferumoxytol and methods of administration.Magn Reson Med 75:2107–2111, 2016. © 2016 Wiley Periodicals, Inc.